Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymalfasin in unresectable hepatocellular carcinoma
NCT00082082Phase 2Completed
- Sponsor
- SciClone Pharmaceuticals (Holdings) Limited
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in hepatocellular carcinoma (HCC), sponsored by SciClone Pharmaceuticals (Holdings) Limited. Status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00082082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082082.